Gerald Marvin Goltz, M.D.

NPI 1720033244ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Sewickley, PA

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Sewickley, Pennsylvania, trained at University of Pittsburgh School of Medicine (class of 1973). Their prescriptions cost Medicare Part D more than their services did: $3,667,123 for 9,670 claims, against $85,596 paid for services in 2024. Novo Nordisk Inc was the largest of 25 companies reporting payments in 2025, $2,115 in all, mostly food and beverage.

Overview

NPI	1720033244
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	May 23, 2006
Last updated in NPPES	Apr 9, 2025
Certified by provider	Apr 9, 2025

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary	207RE0101X	MD-015354-E	PA
Internal Medicine, Nephrology	207RN0300X	MD-015354-E	PA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Endocrinology (PA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	431
Services billed	1,091 across 14 procedure codes
Paid by Medicare	$85,596

Part D prescriptions in 2024

Prescriptions (claims)	9,670 · 23,124 30-day fills
Patients	1,158
Total drug cost	$3,667,123
Generic share	46% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Pittsburgh School of Medicine
Graduation year	1973
Medicare specialty	Endocrinology
Secondary specialties	Nephrology
Telehealth	Offers telehealth